Wait-and-see a winning approach for AOM in more ways than one

By  

Inpharma, Vol. 1, Iss. 1555, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Cardiovascular hybrid drugs: combination of more than one pharmacological property in one single molecule

By Christiaans J.A.M.   Timmerman H.  

European Journal of Pharmaceutical Sciences, Vol. 4, Iss. 1, 1996-01 ,pp. : 1-22

Elsevier

Access to resources Recommend Favorite

Neurotensin is an antagonist of the human neurotensin NT 2 receptor expressed in Chinese hamster ovary cells

By Vita N.   Oury-Donat F.   Chalon P.   Guillemot M.   Kaghad M.   Bachy A.   Thurneyssen O.   Garcia S.   Poinot-Chazel C.   Casellas P.   Keane P.   Le Fur G.   Maffrand J.P.   Soubrie P.   Caput D.   Ferrara P.  

European Journal of Pharmacology, Vol. 360, Iss. 2, 1998-11 ,pp. : 265-272

Elsevier

Access to resources Recommend Favorite

Relevance of Dopamine D2/Neurotensin NTS1 and NMDA/Neurotensin NTS1 Receptor Interaction in Psychiatric and Neurodegenerative Disorders

By  

Current Medicinal Chemistry, Vol. 19, Iss. 3, 2012-01 ,pp. : 304-316

Bentham Science Publishers

Access to resources Recommend Favorite

Target-mediated drug disposition model for drugs that bind to more than one target

By Gibiansky Leonid   Gibiansky Ekaterina  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 37, Iss. 4, 2010-08 ,pp. : 323-346

Springer Publishing Company

Access to resources Recommend Favorite